Home/Orexo/Robert Rönn
RR

Robert Rönn

SVP & Head of R&D

Orexo

Orexo Pipeline

DrugIndicationPhase
Izipry™Opioid OverdoseFiled
OX640Anaphylaxis RescueClinical Development
OX124Opioid Overdose RescueNot Specified
OX390Polysubstance OverdosePreclinical
AmorphOX GLP-1Metabolic DisordersPreclinical
AmorphOX VaccineInfectious DiseasePreclinical